All studies (93) | Randomized (29) | Non-randomized (64) | |
---|---|---|---|
Study type (n (%)) | |||
Drug | 18 (19%) | 9 (31%) | 9 (14%) |
Biological | 12 (13%) | 0 (0%) | 12 (19%) |
Behavioral | 4 (4%) | 1 (3%) | 3 (5%) |
Device | 20 (22%) | 8 (28%) | 12 (19%) |
Diagnostic test | 6 (7%) | 1 (3%) | 5 (8%) |
Dietary supplement | 3 (3%) | 2 (7%) | 1 (2%) |
Procedure | 22 (24%) | 7 (24%) | 15 (23%) |
Other | 8 (9%) | 1 (3%) | 7 (11%) |
Research Domain (n (%)) | |||
Anesthesia, resuscitation | 12 (13%) | 4 (6%) | 8 (28%) |
Biology and physiology | 6 (6%) | 4 (6%) | 2 (7%) |
Clinical Investigation | 3 (3%) | 1 (2%) | 2 (7%) |
Clinical Pharmacology | 2 (2%) | 2 (3%) | 0 0%) |
Emergency Departments | 2 (2%) | 2 (3%) | 0 (0%) |
Medical Specialties | 30 (32%) | 23 (36%) | 7 (25%) |
Neurology | 6 (6%) | 4 (6%) | 2 (7%) |
Odontology | 1 (1%) | 1 (2%) | 0 (0%) |
Pediatrics | 5 (5%) | 4 (6%) | 1 (3%) |
Pneumonology | 3 (3%) | 1 (2%) | 2 (7%) |
Psychiatry | 4 (4%) | 1 (2%) | 3 (10%) |
Public health | 4 (4%) | 4 (6%) | 0 (0%) |
Radiology | 6 (6%) | 6 (9%) | 0 (0%) |
Surgery | 9 (10%) | 7 (11%) | 2 (7%) |
Completion year (median [IQR]) | 2018 [2015; 2019] | 2018 [2015; 2019] | 2017 [2015; 2019] |
Trial sample size (median [IQR]) | 50 [25; 120] | 80 [33; 140] | 49 [25; 114] |
Total budget (Euros) median [IQR] | 38834 [19591; 95260] | 88131 [37349; 331250] | 34805 [11043; 57363] |
Study outcome (n (%)) | |||
Positive | 50 (54%) | 12 (41%) | 38 (59%) |
Negative | 30 (32%) | 13 (45%) | 17 (27%) |
Unknown | 13 (14%) | 4 (14%) | 9 (14%) |